首页> 外文期刊>Brain & Development >Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
【24h】

Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.

机译:给予丙戊酸的大鼠的血清和肝组织生物素酶活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Valproic acid (VPA) is an antiepileptic drug widely used and well-tolerated by most of patients. Its non-dose-dependent side effects seen mostly are the temporary gastrointestinal disturbances including anorexia and nausea, and hepatoxicity. As to its dose-dependent side effects are the weight loss, tremor, skin eruption and the alopecia. In this study we aimed to put forward the biotinidase deficiency considered as a possible cause of alopecia in the rats administered with valproic acid, and the correlation between liver and serum biotinidase enzyme activities (BEA) and transaminases, albumin and serum valproic acid levels. In our study, 4 groups of which one of them was a control group, each consisting of 15 male Wistar rats was organized. 200, 400, and 600mg/kg/day of VPA, and distilled water, two divided doses per day, were administered per orally to VPA-1, VPA-2, VPA-3, and control group, respectively, in 60 days. Their serum and liver biotinidase enzyme activities, serum AST, ALT, albumin, and valproic acid levels were measured. Alopecia was seen in the subjects of 6.6% of VPA-1, 13.3% of VPA-2, and 26.6% of VPA-3. Significant difference in the liver tissues BEA was noted only between VPA-3 and the control group. Reductions were observed both in the liver tissues BEA and the serum BEA levels, which are inversely proportional to the VPA doses. A positive correlation between the liver biotinidase enzyme activities and the serum valproic acid levels, and the negative correlation between the liver tissues biotinidase activities and the serum valproic acid levels were noted, respectively. As a conclusion, the partial alopecia which is an initial symptom of reduced biotinidase activity may also be created depending on the reduction of biotinidase activity during valproic acid therapy. The alopecia which may further be observed in the patients receiving valproic acid therapy may be prevented by means of administration of biotin in a dose of 10mg/day.
机译:丙戊酸(VPA)是一种抗癫痫药,被大多数患者广泛使用和耐受。其非剂量依赖性副作用主要是暂时性胃肠道不适,包括厌食和恶心,以及肝毒性。至于其剂量依赖性的副作用是体重减轻,震颤,皮肤萌发和脱发。在这项研究中,我们的目的是提出被认为是丙戊酸大鼠中脱发的可能原因的生物素酶缺乏症,以及肝脏和血清生物素酶活性(BEA)与转氨酶,白蛋白和血清丙戊酸水平之间的相关性。在我们的研究中,分为4组,其中一组为对照组,每组由15只雄性Wistar大鼠组成。在60天内分别将200、400和600mg / kg /天的VPA和蒸馏水(每天两次)分别口服给VPA-1,VPA-2,VPA-3和对照组。测量他们的血清和肝脏生物素酶活性,血清AST,ALT,白蛋白和丙戊酸水平。 VPA-1为6.6%,VPA-2为13.3%和VPA-3为26.6%时发现脱发。仅在VPA-3和对照组之间注意到肝组织BEA的显着差异。肝组织BEA和血清BEA水平均降低,与VPA剂量成反比。分别注意到肝脏生物素酶活性与血清丙戊酸水平呈正相关,而肝脏组织生物素酶活性与血清丙戊酸水平呈负相关。结论是,取决于丙戊酸治疗期间生物素酶活性的降低,还可能产生作为生物素酶活性降低的初始症状的部分脱发。通过以10mg /天的剂量施用生物素可以预防在接受丙戊酸治疗的患者中可能进一步观察到的脱发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号